| Company | Value | Change | %Change |
|---|
Price band for the issue has been fixed between ₹1,265 – ₹1,329 per equity share, according to available information. The issue is entirely an Offer For Sale (OFS), which means that none of the IPO proceeds will go to the company.
Investors can place their bids for one lot of 11 shares and in multiples thereafter. One lot will entail a total investment of ₹14,619.
IKS Health shares will carry a face value of ₹1 each.
Majority of the issue (75%) has been reserved for institutional investors or Qualified Institutioal Bidders (QIB). 15% of the issue has been reserved for HNIs, while only 10% of the issue has been allocated to retail investors.
Around 65,000 shares worth ₹8.64 crore are also reserved for existing employees.
Selling shareholders in the IPO include the Ashra Family Trust, Joseph Benardello, Gautam Cha,r, Parminder Boina, Aryaman Jhunjhunwala Discretionary Trust, Aryavir Jhunjhunwala Discretionary Trust, Nishtha Jhunjhunwala Discretionary Trust, Jeffery Phillip Freimark, Shane Hsuing Peng, and Berjis Minoo Desai.
IKS Health is a tech-enabled healthcare solutions provider for physician enterprises in the US, Canada and Australia.
As per reports, the current Grey Market Premium (GMP) for the shares of IKS Health is at ₹24 per share ahead of the IPO opening.
